Speaker illustration

Professor Michal Vrablik

Charles University of Prague, Prague (Czechia)

Member of:

European Society of Cardiology

Michal Vrablik M.D., Ph.D. is currently a Professor of Internal Medicine at the 1st Faculty of Medicine, Charles University in Prague, the Czech Republic. His main interests include preventive cardiology, clinical lipidology, CVD risk reduction strategies with special focus on very high-risk group (e.g. type 2 diabetes), and genetics of lipoprotein metabolism disorders. He is most recently involved in studying cardiovascular prevention strategies in different population groups and pharmacogenetic studies. He is the chairman of the Czech Atherosclerosis Society, member of board of the Czech Society of Internal Medicine and the chairman of the Czech Association of Preventive Cardiology. He serves as the chairman of the European Federation of International Atherosclerosis Society and is a steering committee member of the International Lipid Expert Panel. Dr. Vrablik has authored and co-authored more than 400 papers in peer-reviewed scientific journals.

Moderated ePoster 11

Event: ESC Preventive Cardiology 2023

Topic: Lipids

Session type: Moderated ePosters

Thumbnail

Essentials - beyond LDL: new targets and new treatments in lipid disorders

Event: ESC Preventive Cardiology 2023

Topic: Lipids

Session type: Special Session

Thumbnail

Are we ever going to get to lipid goals?

Event: ESC Congress 2016

Topic: Primary cardiovascular prevention: interventions and outcomes

Session type: Moderated Posters

Thumbnail

ESC 365 is supported by